» Articles » PMID: 19767311

GABAergic Differentiation Induced by Mash1 is Compromised by the BHLH Proteins Neurogenin2, NeuroD1, and NeuroD2

Overview
Journal Cereb Cortex
Specialty Neurology
Date 2009 Sep 22
PMID 19767311
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

During forebrain development, Mash1 directs gamma-aminobutyric acid (GABA)ergic neuron differentiation ventrally in the ganglionic eminences. Repression of Mash1 in the cortex is necessary to prevent the formation of GABAergic interneurons. Negative regulation of Mash1 has been attributed to members of the Neurogenin family; the genetic ablation of Neurogenin2 (Ngn2) leads to the derepression of Mash1 and the formation of ectopic GABAergic neurons in the cortex. We have developed an in vitro system to clarify the importance of NeuroD proteins in the Mash1 regulatory pathway. Using a neurosphere culture system, we show that the downstream effectors of the Ngn2 pathway NeuroD1 and NeuroD2 can abrogate GABAergic differentiation directed by Mash1. The ectopic expression of either of these genes in Mash1-expressing cells derived from the lateral ganglionic eminence, independently downregulate Mash1 expression without affecting expression of distal less homeodomain genes. This results in a complete loss of the GABAergic phenotype. Moreover, we demonstrate that ectopic expression of Mash1 in cortical progenitors is sufficient to phenocopy the loss of Ngn2 and strongly enhances ectopic GABAergic differentiation. Collectively, our results define the compensatory and cross-regulatory mechanisms that exist among basic helix-loop-helix transcription factors during neuronal fate specification.

Citing Articles

Klf10 Regulates the Emergence of Glial Phenotypes During Hypothalamic Development.

Garduno-Tamayo N, Almazan J, Romo-Rodriguez R, Valle-Garcia D, Meza-Sosa K, Perez-Dominguez M J Neurosci Res. 2025; 103(2):e70020.

PMID: 39924964 PMC: 11808290. DOI: 10.1002/jnr.70020.


SOXC Enhances NGN2-Mediated Reprogramming of Glioblastoma Cells Into Neuron-Like Cells by Modulating RhoA and RAC1/CDC42 Pathway Activity.

Yang J, Zhu X, Wang F, Chen Z, Zhang Y, Chen J CNS Neurosci Ther. 2024; 30(10):e70075.

PMID: 39390804 PMC: 11467166. DOI: 10.1111/cns.70075.


Controlling the Expression Level of the Neuronal Reprogramming Factors for a Successful Reprogramming Outcome.

Mseis-Jackson N, Sharma M, Li H Cells. 2024; 13(14.

PMID: 39056804 PMC: 11274869. DOI: 10.3390/cells13141223.


Interaction between Oligodendrocytes and Interneurons in Brain Development and Related Neuropsychiatric Disorders.

Liu Y, Yuan J, Dong Y, Jiang S, Zhang M, Zhao X Int J Mol Sci. 2024; 25(7).

PMID: 38612430 PMC: 11011273. DOI: 10.3390/ijms25073620.


Reprogramming of astrocytes to neuronal-like cells in spinal cord injury: a systematic review.

Alizadeh S, Jalalifar M, Ghodsi Z, Sadeghi-Naini M, Malekzadeh H, Rahimi G Spinal Cord. 2024; 62(4):133-142.

PMID: 38448665 DOI: 10.1038/s41393-024-00969-8.